Browse News
Filter News
Found 203 articles
-
ProMIS Neurosciences Publishes in the Journal of Biological Chemistry on the Interaction Between Pathogenic Proteins as a Treatment Target for ALS
4/9/2024
ProMIS Neurosciences Inc. today announced the publication of supportive preclinical data in the Journal of Biological Chemistry in an article titled, “Tryptophan residues in TDP-43 and SOD1 modulate the cross-seeding and toxicity of SOD1."
-
Artificial Intelligence (AI) in Life Sciences Market Projected to Soar USD 9,800 Million by 2032
12/6/2023
The global artificial intelligence (AI) in life sciences market size was estimated at USD 1,560 million in 2022 and is projected to soar USD 9,800 million in 2032, with a double digit CAGR of 20.21% from 2023 to 2032.
-
AI in Healthcare Diagnosis Market Report – Reach $66.81 Billion with 44% CAGR during 2020-2027 | The Insight Partners
5/15/2023
The Insight Partners published latest research report on "Global Artificial Intelligence in Healthcare Diagnosis Market Size Report, Share, Trends, Growth & Forecast to 2027 – COVID-19 Impact and Global Analysis – By Diagnostic Tool; Application; End User; and Service”, the global market is expected to reach USD 66,811.97 million by 2027 from USD 3,639.02 million in 2019.
-
Gwangju Institute of Science and Technology Researchers Develop a Novel Thermoelectric Generator Inspired from Zebra Skin
3/9/2023
Thermoelectric generators are devices that can convert temperature gradients to electricity.
-
Nanox Announces Fourth Quarter 2022 Financial Results and Provides Business Update
3/9/2023
NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the fourth quarter ended December 31, 2022 and provided a business update.
-
Zevra Therapeutics Begins Trading as ZVRA
3/1/2023
Zevra Therapeutics (NasdaqGS: ZVRA) (“Zevra” or the “Company” and formerly KemPharm, Inc.), a rare disease therapeutics company, announced today that it will begin trading under the new ticker symbol “ZVRA” on the Nasdaq Global Select Market at market open today, March 1, 2023.
-
Zevra Therapeutics Reiterates Commitment to Rare Disease Community as New Corporate Council Member of the National Organization for Rare Disorders (NORD)
2/28/2023
Zevra Therapeutics, Inc. announced that it has become a Corporate Council member of the National Organization for Rare Disorders and reiterated its commitment to the rare disease community by celebrating Rare Disease Day 2023.
-
KemPharm Announces Corporate Name Change to Zevra Therapeutics
2/22/2023
KemPharm, Inc. announced today that it changed its name to Zevra Therapeutics, Inc. (“Zevra”).
-
Agios Pharmaceuticals to Present Broad Set of Clinical and Translational Data in Chronic Hemolytic Anemias at 64th ASH Annual Meeting and Exposition
11/3/2022
Agios Pharmaceuticals, Inc. announced that a broad set of clinical and translational data from its programs in hemolytic anemias, including PK deficiency, thalassemia and sickle cell disease, will be presented at the 64th American Society of Hematology Annual Meeting & Exposition, to be held Dec. 10-13, 2022, in New Orleans.
-
BlueWind Medical Announces New Executive Appointments
11/1/2022
BlueWind Medical, Ltd., a medical device company transforming neuromodulation therapy for overactive bladder, announced three executive appointments to leadership positions within the company.
-
Artificial Intelligence In Diagnostics Market Size to Exceed USD 5.9 BN by 2030
10/18/2022
The global Artificial Intelligence In Diagnostics market size was estimated at USD 580.3 million in 2021 and is expected to surpass around USD 5.9 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 26.7% during the forecast period 2022 to 2030.
-
Artificial Intelligence (AI) In Life Sciences Market Size to Exceed USD 6.20 BN by 2030
10/18/2022
According to Nova one advisor, the global Artificial Intelligence (AI) in Life Sciences market size is expected to hit around USD 6.20 billion by 2030 from valued at USD 1.9 billion in 2021 and growing at a CAGR of 20.4% from 2022 to 2030.
-
Medical Holography Market To Reach USD 2.45 Billion By 2027 at a CAGR of 27.6% | Reports and Data
9/13/2022
According to the current analysis of Reports and Data, the global Medical Holography market was valued at USD 346.8 million in 2019 and is expected to reach USD 2.45 billion by the year 2027, at a CAGR of 27.6%.
-
Artificial Intelligence in Diagnostics Market: Increasing Utilization of AI in Different Medical Care Fields to Drive the Market
9/5/2022
The increasing need for improving patient care and reducing treatment costs is a primary factor augmenting the growth of global artificial intelligence in the diagnostics market.
-
Cognesy Therapeutics Announces Senior Leadership Team to Advance Neuroplasticity Drug Discovery Platform for Neuropsychiatric Disorders
8/25/2022
Cognesy Therapeutics, a recently established company developing a platform for the discovery of neuroplasticity-inducing drugs to treat a wide range of neuropsychiatric disorders, announced appointments of its senior leadership team, the company said today.
-
Artificial Intelligence Market Size to Hit US$ 1,811.9 Billion by 2030
8/10/2022
Latest Study on “Artificial Intelligence Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030”.
-
Artificial Intelligence In Diagnostics Market 2022 Industry Growth, Top Key Players, Segmentation and Forecast till 2030
8/10/2022
According to Nova one advisor’s latest research report on the global Artificial Intelligence In Diagnostics market size was estimated at USD 580.3 billion in 2021 and is expected to surpass around USD 5.9 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 26.7% during the forecast period 2022 to 2030.
-
AI In Medical Imaging Market Size to Hit US$ 20.18 Billion by 2030
8/10/2022
According to Nova one advisor’s latest research report on the The global AI in Medical Imaging market gathered revenue around USD 20.18 billion by the end of 2030 and is estimated to expand at a modest CAGR of 36.9% during the prediction period 2022 to 2030.
-
Butterfly Network Reports Second Quarter 2022 Financial Results
8/3/2022
Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ultrasound, announced financial results for the quarter ended June 30, 2022, and provided a business update.
-
Artificial Intelligence (AI) in MRI Market Size to Reach at USD 9.78 Billion by 2030
7/12/2022
According to Vision Research Reports, the global artificial intelligence in medical imaging market size was valued at USD 5.1 billion in 2021 and is expected to reach at USD 9.78 billion by 2030, poised to grow at a CAGR of 7.5% from 2022 to 2030.